Delivered on Quarterly Revenue and EBITDA Guidance Reiterate full year Revenue and Adjusted EBITDA guidance Quarterly Revenue of $21.2 million in Q1, representing 20% YoY growth Reduced Q1 Net Loss by 36% and Net Cash Used in Operations by 43% Raised $81.7 million of net proceeds through a public offering closed on January 31, 2025 Initiated clinical phase of Butterfly HomeCare congestive heart failure pilot program Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced financial results for the first quarter ended March 31, 202

Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report first quarter 2025 financial results on May 2, 2025 before the market opens. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice President and Chief Financial and Operations Officer, will host a conference call and webcast at 8:00 am ET on May 2 to discuss the financial performance and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly's Investor Relations website at Eve

Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly") a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will participate at the Virtual Oppenheimer 35th Annual Healthcare MedTech & Services Conference on March 18, 2025. Joseph DeVivo, President, Chief Executive Officer & Chairman and Heather Getz, Executive Vice President & Chief Financial and Operations Officer will host one-on-one investor meetings and take part in a Fireside Chat at 11:20am EDT. A webcast of the Fireside Chat will be available in the Events & Presentations section of the Butterfly investor website. To schedule a one-on-one meeting with Mr. DeVivo

Delivered Record Annual and Quarterly Revenue Delivered quarterly record Revenue of $22.4 million in Q4, representing 35% YoY growth Reduced Q4 Net Loss by 59% and Net Cash Used in Operations by 76% Successful public offering closed on January 31, 2025 with $81.7 million of net proceeds Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced financial results for the fourth quarter and year ended December 31, 2024, and provided a business update. Joseph DeVivo, Butterfly's President, Chief Executive Officer and Chairman comment

Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly") a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will present and host one-on-one investor meetings at the TD Cowen 45th Annual Health Care Conference in Boston on March 3, 2025. Heather Getz, Executive Vice President & Chief Financial and Operations Officer will host one-on-one meetings and will present a business overview at 1:10pm EST. A webcast of the presentation will be available in the Events & Presentations section of the Butterfly investor website. About Butterfly Network Butterfly Network, Inc. (NYSE:BFLY) is a healthcare company driving a digital revo

Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report fourth quarter and full year 2024 financial results on Friday, February 28, 2025, at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice President and Chief Financial and Operations Officer, will host a conference call and webcast before the market opens on February 28 to discuss the financial performance and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly

Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced the pricing of an underwritten public offering of 24,000,000 shares of its Class A common stock (the "Common Stock"), at a public offering price of $3.15 per share. The gross proceeds to Butterfly from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $75.6 million. Butterfly has granted the underwriters a 30-day option to purchase up to an additional 3,600,000 shares of Common Stock at the public offering

Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced it has commenced an underwritten public offering of Class A common stock ("Common Stock"). Butterfly also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of Common Stock sold in the public offering. All of the shares of Common Stock are being offered by Butterfly. Butterfly intends to use the net proceeds from this offering to fund the development and commercialization of new and existing products and services, as well as for general

Study demonstrates significant reductions in length of stay and healthcare costs, advocating for broader adoption of POCUS in hospital settings. Butterfly Network, Inc. ("Butterfly", "the Company") (NYSE:BFLY), a digital health company transforming care with handheld, whole-body ultrasound today announced preliminary findings from a seminal study conducted by Rutgers Robert Wood Johnson Medical School (RWJMS) and Robert Wood Johnson University Hospital (RWJUH), an RWJBarnabas Health facility, demonstrating the transformative impact of point-of-care ultrasound (POCUS) on patient outcomes and hospital efficiency. A late-breaking clinical trial presentation of the data was disseminated at th

The Company will present a business update at the 43rd J.P. Morgan Healthcare Conference on January 16, 2025 at 7:30 am PST. Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly", "the Company"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced that it expects to report revenue growth for the fourth quarter ended December 31, 2024 of approximately 35% year over year. Joseph DeVivo, Butterfly's President, Chief Executive Officer and Chairman commented, "The Butterfly team closed out 2024 strong, with yet another standout performance in the final quarter. Our preliminary unaudited results show we exceede

Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report first quarter 2025 financial results on May 2, 2025 before the market opens. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice President and Chief Financial and Operations Officer, will host a conference call and webcast at 8:00 am ET on May 2 to discuss the financial performance and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly's Investor Relations website at Eve

Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report fourth quarter and full year 2024 financial results on Friday, February 28, 2025, at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice President and Chief Financial and Operations Officer, will host a conference call and webcast before the market opens on February 28 to discuss the financial performance and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly

Delivered Quarterly Revenue of $20.6mm, 33% YoY Growth Raises Full Year Revenue and Adjusted EBITDA Guidance Delivered quarterly Revenue of $20.6 million in Q3, representing 33% YoY growth Reduced Q3 Net Loss by 38% and Net Cash Used in Operations by 50% Launched iQ3 in Europe and opened new markets in Indonesia, the Netherlands, and Belgium Announced the formation of Octiv™, a wholly owned subsidiary focused on bringing Butterfly's chip to new sectors Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced financial results for th

Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report third quarter 2024 financial results on November 1, 2024 at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice President and Chief Financial and Operations Officer, will host a conference call and webcast before the market opens on November 1 to discuss third quarter 2024 financial performance and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly's Investor

Reports Record Quarterly Revenue Raises Full Year Adjusted EBITDA Guidance Delivered record quarterly Revenue of $21.5 million in Q2, representing 16% YoY growth Reduced Q2 Net Loss by 45% and Net Cash Used in Operations by 62% Successfully launched medical school Campus Essentials program Launched iQ3 in Canada and expanded into new markets in Southeast Asia Filed for revocation of the RoHS handheld piezoelectric crystal ultrasound exemptions Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced financial results for t

07/18/2024 Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report second quarter 2024 financial results on August 1, 2024, after the market closes. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice President and Chief Financial and Operations Officer, will host a conference call and webcast at 5:00 pm ET on August 1, 2024, to discuss second quarter 2024 financial results and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on But

Achieves 14% Revenue Growth - Exceeding Expectations Raises Full Year Guidance Delivered record first quarter Revenue of $17.7 million Reduced Net Loss by 35% and Net Cash Used in Operations by 52% Successfully launched next generation device Butterfly iQ3™ and training app ScanLab™ Received European Union Medical Device Regulation (EU MDR) certification Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced financial results for the first quarter ended March 31, 2024, and provided a business update. Joseph DeVivo, Butterfly's Chairman and CEO

Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a digital health company transforming care with handheld, whole-body ultrasound, announced that it will report first quarter 2024 financial results on May 1, 2024, after the market closes. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice President and Chief Financial and Operations Officer, will host a conference call and webcast at 5:00 pm ET on May 1, 2024, to discuss first quarter 2024 financial results and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly's Investor Relations website at Events & Presentations.

Completed Cost Savings and New Initiatives Position Butterfly for Growth Delivered $65.9 million of Revenue – better than expectations Launched next generation device iQ3 and ScanLab in 2024 Completed the removal of over $170 million in costs from the business Reduced annual cash burn to approximately $60 million Announced upcoming Investor Day on March 18, 2024, at the New York Stock Exchange Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), an innovative digital health company transforming care through a unique combination of portable, semiconductor-based ultrasound technology, intuitive software, services and educational offerings that can make medical

Company to Hold Investor Day on March 18, 2024, at the New York Stock Exchange Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a digital health company transforming care with handheld, whole-body ultrasound, today announced that it will report fourth quarter and full year 2023 financial results on Wednesday, February 28, 2024, after the market closes. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice President and Chief Financial and Operations Officer, will host a conference call and webcast at 5:00 pm ET, February 28, 2024, to discuss the financial results and operational progress. The conference call will be broadcast l

Seasoned Healthcare Leader to Drive Growth Strategy and Amplify Continued Commercial Momentum Butterfly Network, Inc. (NYSE:BFLY), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced the appointment of Steve Cashman as Chief Business Officer (CBO), effective today. Cashman joins Butterfly at an exciting juncture, following the Company's successful launch of its third-generation Butterfly iQ3 and historic revenue performance in the first half of 2024. Cashman will join Butterfly's Executive Management Team, overseeing the Company's global sales, marketing, product and corporate strategy. This press release f

SAN FRANCISCO, Aug. 20, 2024 /PRNewswire/ -- Avive Solutions, Inc., a manufacturer of innovative Automated External Defibrillators (AEDs) and software solutions to improve access to AEDs and response to cardiac arrest emergencies, is excited to announce the appointment of Katerina Miras as their Vice President of Marketing. A visionary marketing leader with extensive experience in medtech, Miras brings a wealth of expertise in creating memorable healthcare brands that accelerate commercial growth. "I am honored to join Avive's leadership team at such a transformative time for

Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Heather Getz as a Class II director and chair of its audit committee effective March 26, 2024, to serve until the 2025 annual meeting of stockholders. With this appointment, Myomo has seven directors. Ms. Getz brings more than 25 years of corporate experience creating long-term value through financial, general management, and healthcare leadership. She has significant expertise in finance, reimbursement, investor relations, compliance, M&A and strategic plannin

Health Tech Executive Brings More Than 35 Years of Business Experience and Operational Excellence to Butterfly Butterfly Network, Inc., a digital health company transforming care through the power of handheld, whole-body ultrasound, has announced the appointment of Joseph M. DeVivo as its new President and Chief Executive Officer (CEO), effective immediately. Mr. DeVivo will also join Butterfly's Board of Directors, serving as Chairman. DeVivo brings over 35 years of business leadership experience, having held leadership positions at healthcare and medical device companies, as well as non-profit organizations. Prior to joining Butterfly, DeVivo served as President of Hospitals and Healt

Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" the "Company"), a digital health company transforming care with handheld, whole-body ultrasound, announced that the Company and Todd Fruchterman, M.D., Ph.D. have mutually agreed that Dr. Fruchterman will leave his position as President and Chief Executive Officer and as a member of the Board of Directors. Dr. Fruchterman will partner with Butterfly's leadership team through the end of the year to ensure a smooth transition. "On behalf of the Board I want to thank Todd for his vision, passion and dedication to Butterfly during his tenure," said Jonathan Rothberg, Founder and Chairman of the Board. "Todd has built a highly capable leadership

Company Announces Hiring of Tamara Dillon as Chief People Officer and Larry Weiss as Chief Legal Officer and Corporate Secretary Both Executives Bring Healthcare, Public Company, and Growth Experience to their Respective Roles Butterfly Network, Inc. (NYSE:BFLY), a digital health company transforming care with handheld, whole-body ultrasound, today announced the appointment of Tamara Dillon to the position of Chief People Officer (CPO), effective May 31, and Larry Weiss to the position of Chief Legal Officer and Corporate Secretary, effective May 23. "The addition of Tamara and Larry brings two extraordinary leaders with great depth of experience working within public companies, scaling

Former Google Health Executive to Expand Cardiovascular Strategy for Ocular Health Technology Company Tesseract Health, a health technology company developing a portable, non-invasive platform to detect health conditions through the eyes, proudly announces the appointment of Michael McConnell, MD, MSEE, as Tesseract's Head of Cardiovascular and Digital Health. This key role completes Tesseract's leadership team and coincides with a series of critical, strategic hires under the helm of CEO Vicky Demas, PhD. Dr. McConnell was brought on to leverage Tesseract's technology to guide the expansion of its cardiovascular strategy. In this role, he is poised to lead and champion the design, planni

Health Tech Executive Brings 25 years of Financial and Operational Experience to Butterfly Butterfly Network, Inc. (NYSE:BFLY), a digital health company transforming care with handheld, whole-body ultrasound, today announced the appointment of Heather Getz to the position of Executive Vice President and Chief Financial Officer, effective May 2. "Heather brings a compelling blend of healthcare technology and public company experience along with a successful track record in operational and financial discipline that is well suited to support and enhance Butterfly's continued growth and evolution," ​said Dr. Todd Fruchterman, Butterfly's President and Chief Executive Officer. "As a proven CFO

Dr. Erica Schwartz joins Butterfly's Board of Directors Troy Quander joins Butterfly as Senior Vice President, Regulatory and Quality Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), an innovative digital health company that is working to democratize medical imaging and contribute to the aspiration of global health equity, today announced the expansion of its Board of Directors to nine directors through the appointment of Dr. Erica Schwartz and the addition of Troy Quander to the leadership team as Senior Vice President, Regulatory and Quality. These appointments continue to strengthen the technical foundation of the company to ensure that it can effectively execute its mission of dem

Dr. Andrei Stoica and David Ramsey will lead the effort to strengthen innovation and technology infrastructure as Chief Technology Officer and Chief Information Officer, respectively.   Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), an innovative digital health company that is working to democratize medical imaging and enable global health equity, today announced that effective July 19, Dr. Andrei Stoica will be joining Butterfly as Chief Technology Officer (CTO), and David Ramsey will be joining as Chief Information Officer (CIO). In this newly created executive position, Dr. Stoica will lead Butterfly's product development, technology innovation, and information technology operation

4 - Butterfly Network, Inc. (0001804176) (Issuer)

4 - Butterfly Network, Inc. (0001804176) (Issuer)

4 - Butterfly Network, Inc. (0001804176) (Issuer)

4 - Butterfly Network, Inc. (0001804176) (Issuer)

4 - Butterfly Network, Inc. (0001804176) (Issuer)

4 - Butterfly Network, Inc. (0001804176) (Issuer)

4 - Butterfly Network, Inc. (0001804176) (Issuer)

4 - Butterfly Network, Inc. (0001804176) (Issuer)

4 - Butterfly Network, Inc. (0001804176) (Issuer)

4 - Butterfly Network, Inc. (0001804176) (Issuer)

William Blair initiated coverage of Butterfly Network with a rating of Outperform

Lake Street initiated coverage of Butterfly Network with a rating of Buy and set a new price target of $3.00

UBS initiated coverage of Butterfly Network with a rating of Neutral and set a new price target of $2.25

Oppenheimer initiated coverage of Butterfly Network with a rating of Outperform and set a new price target of $4.50

B. Riley Securities initiated coverage of Butterfly Network with a rating of Buy and set a new price target of $9.50

UBS initiated coverage of Butterfly Network with a rating of Neutral and set a new price target of $7.00

Cowen initiated coverage of Butterfly Network with a rating of Outperform and set a new price target of $20.00

144 - Butterfly Network, Inc. (0001804176) (Subject)

10-Q - Butterfly Network, Inc. (0001804176) (Filer)

8-K - Butterfly Network, Inc. (0001804176) (Filer)

DEFA14A - Butterfly Network, Inc. (0001804176) (Filer)

DEF 14A - Butterfly Network, Inc. (0001804176) (Filer)

144 - Butterfly Network, Inc. (0001804176) (Subject)

SCHEDULE 13D/A - Butterfly Network, Inc. (0001804176) (Subject)

10-K - Butterfly Network, Inc. (0001804176) (Filer)

8-K - Butterfly Network, Inc. (0001804176) (Filer)

8-K - Butterfly Network, Inc. (0001804176) (Filer)

SC 13D/A - Butterfly Network, Inc. (0001804176) (Subject)

SC 13D/A - Butterfly Network, Inc. (0001804176) (Subject)

SC 13G/A - Butterfly Network, Inc. (0001804176) (Subject)

SC 13G/A - Butterfly Network, Inc. (0001804176) (Subject)

SC 13G/A - Butterfly Network, Inc. (0001804176) (Subject)

SC 13G/A - Butterfly Network, Inc. (0001804176) (Subject)

SC 13D/A - Butterfly Network, Inc. (0001804176) (Subject)

SC 13D/A - Butterfly Network, Inc. (0001804176) (Subject)

SC 13G/A - Butterfly Network, Inc. (0001804176) (Subject)

SC 13G - Butterfly Network, Inc. (0001804176) (Subject)